Moreover, the HH signaling is activated in CRC by ligand-dependent mechanisms with overexpression of SHH [185, 186], as well as the SHH-GLI1 pathway [187] but both pathways, canonical and non-canonical can co-exist in cancer context. Here, GLI1 is linked to colorectal carcinoma.